Table 4.
Unadjusted and adjusted Cox regression model for resumption of prescription aged 20–22 years
| Variable | Unadjusted | Adjusted | ||
|---|---|---|---|---|
| hazard ratio (95% CI) | p value | hazard ratio (95% CI) | p value | |
| Female gender | 1.91 (1.09–3.32) | 0.02 | 1.81 (1.04–3.26) | 0.05 |
| Referral recorded to adult mental health services | 3.27 (2.01–5.31) | < 0.0001 | 2.18 (1.30–3.66) | 0.003 |
| Learning disability | 3.64 (1.98–6.70) | < 0.0001 | 2.43 (1.25–4.74) | 0.009 |
| Conduct disorder | 1.32 (0.61–2.86) | 0.48 | ||
| Autism spectrum disorder | 1.99 (1.09–3.67) | 0.03 | 1.47 (0.76–2.83) | 0.26 |
| Anxiety or depression | 1.57 (0.83–2.96) | 0.16 | ||
| Substance misuse | 2.57 (1.04–6.33) | 0.04 | 1.81 (0.72–4.56) | 0.21 |
| Antidepressant prescription aged 19 and over | 2.08 (1.28–3.41) | 0.004 | 1.08 (0.63–1.86) | 0.77 |
| Antipsychotic prescription aged 19 and over | 6.93 (3.97–12.1) | < 0.0001 | 3.58 (1.86–6.88) | < 0.0001 |
| Anxiolytic/hypnotic prescription aged 19 and over | 3.20 (1.60–6.39) | < 0.001 | 1.83 (0.88–3.80) | 0.10 |
| Age at stopping medication (17 or 18 versus 14–16) | 2.25 (1.43–3.53) | < 0.0001 | 2.04 (1.28–3.24) | 0.003 |